Serum Institute of India Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sep, 2017   |   36  Pages   |   GlobalData   |   Format : PDF

Summary

Serum Institute of India Ltd (SIIL) is a drug development and manufacturing company that manufactures and markets vaccines and biologicals. The company offers polio vaccine, diphtheria, tetanus, pertussis, hib, BCG, r-hepatitis B, measles, mumps and rubella vaccines. It operates through manufactured products, marketed products and exported product segments. SIIL's manufactured products comprise bacterial vaccines, viral vaccines, recombinant and combination vaccines, meningococcal A conjugate vaccine, anti cancer products and anti sera, plasma and hormonal products. The company's exported products include bacterial vaccines, viral vaccines, combination vaccine, influenza vaccine, anti cancer products, and others. It operates in Chennai, Kolkatta, New Delhi, Surat, Trivandrum and Visakhapatnam. SIIL is headquartered in Pune, Maharashtra, India.

Serum Institute of India Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Serum Institute of India Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million 13
Private Equity 14
Serum Institute Plans to Sell Minority Stake in Itself 14
Partnerships 15
Serum Institute of India Enters into Licensing Agreement with St. Jude Children's Research Hospital 15
Cipla Enters into Distribution Agreement with Serum Institute 16
Cipla Enters into Distribution Agreement with Serum Institute of India 17
Merck Enters Into Co-Development Agreement With Serum Institute of India 18
VaxyGen Vaccines Enters Into Collaboration With Serum Institute Of India 19
Licensing Agreements 20
Serum Institute of India Enters into Licensing Agreement with NeuClone 20
Serum Institute of India Enters into Licensing Agreement with Xenetic Biosciences 21
Serum Institute of India Enters into Licensing Agreement with Visterra 22
Genticel Enters into Licensing Agreement with Serum Institute of India 23
Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 24
Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25
BioDiem Enters Into Licensing Agreement With Serum Institute Of India 26
Acquisition 27
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 27
Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million 28
Serum Institute Plans To Sell Its Stake In Akorn 29
Serum Institute of India Ltd - Key Competitors 31
Serum Institute of India Ltd - Key Employees 32
Serum Institute of India Ltd - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Product News 35
11/30/2016: GENTICEL successfully completes determining milestone in partnership with Serum Institute regarding use of GTL003 in multivalent vaccines 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Serum Institute of India Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Serum Institute of India Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million 13
Serum Institute Plans to Sell Minority Stake in Itself 14
Serum Institute of India Enters into Licensing Agreement with St. Jude Children's Research Hospital 15
Cipla Enters into Distribution Agreement with Serum Institute 16
Cipla Enters into Distribution Agreement with Serum Institute of India 17
Merck Enters Into Co-Development Agreement With Serum Institute of India 18
VaxyGen Vaccines Enters Into Collaboration With Serum Institute Of India 19
Serum Institute of India Enters into Licensing Agreement with NeuClone 20
Serum Institute of India Enters into Licensing Agreement with Xenetic Biosciences 21
Serum Institute of India Enters into Licensing Agreement with Visterra 22
Genticel Enters into Licensing Agreement with Serum Institute of India 23
Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 24
Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25
BioDiem Enters Into Licensing Agreement With Serum Institute Of India 26
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 27
Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million 28
Serum Institute Plans To Sell Its Stake In Akorn 29
Serum Institute of India Ltd, Key Competitors 31
Serum Institute of India Ltd, Key Employees 32
Serum Institute of India Ltd, Other Locations 33
Serum Institute of India Ltd, Subsidiaries 34

List of Figures
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Serum Institute of India Ltd, Medical Devices Deals, 2011 to YTD 2017 10

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Fax Number: +91 22 27812707

Follow Us On: